P

PineTree Therapeutics Inc

16 employees

PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
NSCLC
Covid-19
Wellness
Oncology
Bispecific antibody
solid cancer
RSV
HIV
In situ cancer vaccine
Pancreatic cancer
Therapeutics
Infectious Diseases
Medical

Date founded

2019

Funding rounds raised

Total raised

$24M

from 6 investors over 6 rounds

P

PineTree Therapeutics Inc raised undisclosed on September 27, 2022

Investors: Massachusetts Life Sciences Center

P

PineTree Therapeutics Inc raised $24M on June 7, 2022

Investors: DSC Investment, SGI Venture Capital, J-Curve | Insight - Investment - Implementation, SK Securities and InterVest

FAQ